SomaLogic to go public via SPAC in deal that values it as a unicorn
BOULDER — SomaLogic Inc. is launching a merger with a special purpose acquisition company that would add up to $651 million in new funding to the company’s books and make it Colorado’s latest unicorn.
In a statement Monday, the Boulder company said it will merge with CM Life Sciences II (Nasdaq: CMIIU) and give the company up to $686 million on its total balance sheet. The lead entity in charge of CM Life Sciences II is Casdin Capital LLC, a life-sciences investment group with $1.31 billion in assets under management. The current management team will stay in place after the merger.
The…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Tilled Inc., a Boulder payment-facilitation technology company, recently completed a $12.5 million investment round, bringing…
-
A trio of Boulder startup scene veterans is reviving the local Techstars accelerator program, which…
-
Brightwave, Boulder-based AI technology company is “swinging for the fences,” after raising $21 million to…
-
BOULDER — Even with the COVID-10 pandemic several years in the rearview mirror, it remains…
